FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion FDA issued its first warning letter to a dispenser (a medical spa) for violating the Drug Supply Chain Security Act (DSCSA), including failing to source products from authorized trading partners and When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions The Peptide Moment: How FDA's Regulatory Reversal Creates Risk and Opportunity for Venture Capital and Private Equity Guidepost Solutions